NCT04774822View on ClinicalTrials.gov

Validation Study of RETINA-AI Galaxy™, an Automated Diabetic Retinopathy Screening Device

CompletedOBSERVATIONAL
Enrollment

397

Participants

Timeline

Start Date

March 25, 2021

Primary Completion Date

May 28, 2021

Study Completion Date

August 31, 2021

Conditions
Diabetic RetinopathyDiabetic Eye ProblemsDiabetic Macular Edema
Interventions
PROCEDURE

Color Fundus Photography

Stereoscopic Fundus photography

DRUG

Mydriatics Agent

Eye dilating agent

PROCEDURE

Optical Coherence Tomography (OCT)

Optical Tomographic imaging of retina

Trial Locations (3)

77043

Biopharma Informatic, LLC, Houston

77074

Clinical Trial Network, Houston

77084

Biopharma Informatic LLC, Houston

All Listed Sponsors
lead

RETINA-AI Health, Inc.

INDUSTRY

NCT04774822 - Validation Study of RETINA-AI Galaxy™, an Automated Diabetic Retinopathy Screening Device | Biotech Hunter | Biotech Hunter